Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Merck COVID drug linked to new virus mutations, study says

Merck & Co.’s COVID-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen’s genetic code.

Tribune News Service

Tech Futures Jump As Meta Spikes After 'Gratifying' Fed Rally; Apple, Amazon, Google Earnings Next

Tech futures leapt as Meta spiked on its results, following the Fed's "gratifying" market rally. Apple, Amazon, Google earnings are next.

Investors Business Daily

Meet the German shepherd who was the richest dog in the world — and had a huge secret

“Gunther’s Millions”, a new Netflix documentary, investigates the story of Gunther, one in a long line of German Shepherds who had supposedly inherited a fortune from their late owner. Clémence Michallon reports

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Who is Gunther? Inside hoax claims and secrets of world's richest dog in new Netflix doc

Netflix docuseries Gunther's Millions will explore the 'hoax' surrounding the world's richest dog Gunther and the man who cares for him, businessman Maurizio Mian

Daily Mirror

Cancer vaccine trials could start in the autumn – UK signs deal with BioNTech

The UK government recently announced that it is partnering with German firm BioNTech to test vaccines for cancer and other diseases. The project aims to build on the mRNA vaccine technology that BioNTech became famous for developing, and which has been so successful at preventing serious illness and death from…

The Conversation

Best Mutual Funds Report: Bulls In Hibernation In Bear Market

Tech names Nvidia remain absent as medical, oil, retail and machinery stocks top the list of new buys by the best mutual funds in bear market.

Investors Business Daily

IBD Stock Of The Day United Therapeutics Is Braving Competition, And Eyeing Two Entries

United Therapeutics is the IBD Stock Of The Day as competition heats up in its lung disease market. UTHR stock is eyeing two potential buy points.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023?

Merck is navigating a looming patent expiration for its blockbuster Keytruda. Now, Merck stock is trading at its highest point in decades.

Investors Business Daily

Chinese take risks on black-market Covid drugs

BEIJING: Desperate families searching for critical Covid-19 medication in China, faced with bare pharmacy shelves and an explosion of cases, are being driven into murky online marketplaces rife with price gouging and fraud.

Bangkok Post

Chinese take risks on black market drugs as Covid surges

Beijing (AFP) - Desperate families searching for critical Covid-19 medication in China, faced with bare pharmacy shelves and an explosion of cases, are being driven into murky online marketplaces rife with price gouging and fraud.

AFP

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.

Tribune News Service

3 High-Flying Pharma Stocks to Buy Right Now

The healthcare industry is poised to grow significantly in the coming years. Moreover, as healthcare stocks tend to perform relatively well despite macro uncertainties due to inelastic demand for their products and services, high-flying pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Merck & Co (MRK) might be ideal investments…

StockNews.com

Arcus, Gilead Disappoint As Lung-Cancer Regimen Lags Rival Roche

Gilead and Arcus toppled Tuesday after their lung-cancer regimen trailed a rival concoction from Roche. RCUS stock skidded more than 20%.

Investors Business Daily

Red-Hot Fund Managers Expect Rocky Start To 2023

Want to know how to invest in 2023? Red-hot fund manager Dale Harvey says individual investors should fasten their seat belts.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review

The market rally came under pressure on a higher Fed rate outlook. Moderna spiked on a cancer vaccine while Tesla continued to dive.

Al Jazeera

Ebola vaccines produced lasting antibodies during trial: Studies

Studies in West Africa said the vaccines developed by Johnson & Johnson and Merck & Co appear to be safe in children.

Reuters

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies

Ebola vaccines developed by Johnson Johnson and Merck Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.

The Independent UK

Cancer vaccine halves risk of relapse or death using Covid jab technology

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Skin cancer vaccine trial shows promising results

Moderna and Merck team up in new study.

Investors Business Daily

Dow Jones Rallies; Elon Musk Loses This Title As Tesla Tumbles; Bitcoin Up Amid Sam Bankman-Fried Arrest

The Dow Jones moved higher. Tesla CEO Elon Musk lost a famous title. Bitcoin rose after the Sam Bankman-Fried arrest. Moderna stock jumped.

The Street

What the Moderna Cancer Vaccine News Doesn't Mean

Moderna and Merck hailed preliminary results from a combination therapy as a breakthrough, but there are important nuances to consider.

Mic

Researchers from Moderna and Merck just made a breakthrough with a skin cancer vaccine

Thank you, science.

Investors Business Daily

Stock Market Rally, New Breakouts Fade At Midday As CPI Enthusiasm Wanes

The stock market's reaction to the inflation data was swift and decisive.

The Independent UK

Merck, Moderna detail potential skin cancer vaccine progress

Shares of Merck and Moderna jumped early Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study

Investors Business Daily

Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up

Moderna unveiled promising results for its personalized cancer vaccine on Tuesday. The results sent Moderna shares soaring.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations